ketanserin has been researched along with ketanserinol in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (64.71) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barendregt, JN; Tjandra, YI; Van Der Hoeven, JG; Van Oene, JC; Van Peer, A | 1 |
Benhamou, JP; Berthelot, P; Fraitag, B; Gaudin, C; Hadengue, A; Lebrec, D; Levron, JC | 1 |
Gould, S; Gush, R; Jayson, MI; Kay, EA; Klimiuk, PS; Mitchell, WS; Taylor, L | 1 |
Kurowski, M | 1 |
Awouters, F; Heykants, J; Leysen, JE; Michiels, M; Schuurkes, J; Van Nueten, JM; Woestenborghs, R | 1 |
De Cree, J; Hendrickx, J; Heykants, J; Lauwers, W; Meuldermans, W; Van Peer, A; Woestenborghs, R | 1 |
Heykants, J; Knaeps, F; Meuldermans, W; Mostmans, E; Van Houdt, J; Verluyten, W | 1 |
Hedner, T; Persson, B; Pettersson, A | 1 |
Leeser, JE; Rawlins, MD; Williams, FM | 1 |
Embrechts, L; Heykants, J; Van Peer, A; Woestenborghs, R | 1 |
Gould, S; Heykants, J; Mills, J; Van Peer, A; Woestenborghs, R | 1 |
Frenken, M; Kaumann, AJ | 1 |
Lindelauf, F | 1 |
Schoenwald, RD; Zhu, J | 1 |
Hanff, LM; Vulto, AG; Yassen, A | 1 |
Sinclair-Worley, L; Uphouse, L | 1 |
Drozdov, I; Gustafsson, BI; Joseph, R; Kidd, M; Modlin, IM; Pfragner, R; Svejda, B | 1 |
3 trial(s) available for ketanserin and ketanserinol
Article | Year |
---|---|
Pharmacokinetics of ketanserin in patients with cirrhosis.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Female; Humans; Injections, Intravenous; Ketanserin; Liver Cirrhosis; Male; Middle Aged; Models, Biological | 1990 |
Pharmacodynamics and pharmacokinetics of single doses of ketanserin and propranolol alone and in combination in healthy volunteers.
Topics: Adult; Blood Pressure; Drug Administration Schedule; Female; Half-Life; Heart Rate; Humans; Ketanserin; Kinetics; Male; Middle Aged; Physical Exertion; Propranolol; Time Factors | 1986 |
Pharmacokinetics of ketanserin and its metabolite ketanserin-ol in man after intravenous, intramuscular and oral administration.
Topics: Administration, Oral; Adult; Analysis of Variance; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Ketanserin; Kinetics; Male; Random Allocation; Regression Analysis | 1986 |
14 other study(ies) available for ketanserin and ketanserinol
Article | Year |
---|---|
Ketanserin pharmacokinetics in patients with renal failure.
Topics: Adult; Aged; Blood Proteins; Female; Half-Life; Humans; Ketanserin; Kidney Failure, Chronic; Male; Middle Aged; Protein Binding; Renal Dialysis | 1990 |
Ketanserin: an effective treatment regimen for digital ischaemia in systemic sclerosis.
Topics: Administration, Oral; Adult; Aged; Female; Fingers; Humans; Infusions, Intravenous; Ischemia; Ketanserin; Middle Aged; Pain Measurement; Scleroderma, Systemic | 1989 |
Simultaneous determination of ketanserin and ketanserinol in biological fluids using ion-pair liquid chromatography and fluorometric detection.
Topics: Aged; Antihypertensive Agents; Body Fluids; Chromatography, High Pressure Liquid; Female; Humans; Hydrogen-Ion Concentration; Ketanserin; Kinetics; Piperidines; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 1985 |
Pharmacokinetic evaluation of the in vitro and in vivo pharmacological profile of the major metabolites of ketanserin in the rat.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Cricetinae; In Vitro Techniques; Injections, Subcutaneous; Ketanserin; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Receptors, Drug; Stomach Ulcer | 1988 |
Absorption, metabolism and excretion of ketanserin in man after oral administration.
Topics: Administration, Oral; Adult; Biotransformation; Chromatography, High Pressure Liquid; Feces; Humans; Ketanserin; Male | 1988 |
Plasma protein binding of ketanserin and its distribution in blood.
Topics: Administration, Oral; Animals; Blood Proteins; Dogs; Drug Interactions; Humans; Hydrogen-Ion Concentration; Ketanserin; Male; Protein Binding; Rats; Rats, Inbred Strains; Tissue Distribution | 1988 |
Pharmacokinetics of ketanserin in patients with essential hypertension.
Topics: Administration, Oral; Aged; Biological Availability; Female; Half-Life; Hemodynamics; Humans; Hypertension; Injections, Intravenous; Ketanserin; Kinetics; Male; Metabolic Clearance Rate; Middle Aged | 1987 |
Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-ol.
Topics: Administration, Oral; Adult; Half-Life; Humans; Ketanserin; Kinetics; Male; Oxidation-Reduction | 1986 |
Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf.
Topics: Animals; Cattle; Coronary Vessels; In Vitro Techniques; Ketanserin; Muscle Contraction; Muscle, Smooth, Vascular; Piperidines; Pulmonary Artery; Receptors, Serotonin; Yohimbine | 1984 |
Determination of ketanserin and its major metabolite (reduced ketanserin) in human plasma by high-performance liquid chromatography.
Topics: Adult; Chromatography, High Pressure Liquid; Female; Humans; Ketanserin; Oxidation-Reduction; Piperidines; Spectrophotometry, Ultraviolet | 1983 |
The ocular pharmacokinetics of ketanserin and its metabolite, ketanserinol, in albino rabbits.
Topics: Administration, Topical; Animals; Eye; Female; Intraocular Pressure; Ketanserin; Male; Rabbits; Serotonin Antagonists | 2000 |
Simultaneous quantitative analysis of ketanserin and ketanserinol in plasma by RP-HPLC with fluorescence detection.
Topics: Calibration; Chromatography, High Pressure Liquid; Humans; Ketanserin; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2003 |
Effect of estrogen on the lordosis-inhibiting action of ketanserin and SB 206553.
Topics: Analysis of Variance; Animals; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Female; Hypothalamus, Middle; Indoles; Ketanserin; Posture; Progesterone; Pyridines; Rats; Rats, Inbred F344; Serotonin Antagonists; Sexual Behavior, Animal; Time Factors | 2004 |
Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines.
Topics: Cell Line, Tumor; Cell Proliferation; Homeostasis; Humans; Intestinal Neoplasms; JNK Mitogen-Activated Protein Kinases; Ketanserin; Lung Neoplasms; Mitogen-Activated Protein Kinase 3; Neuroendocrine Tumors; Phosphorylation; Receptors, Serotonin; Serotonin; Signal Transduction; Tryptophan | 2009 |